ClinicalTrials.gov
public full text
Public Domain
TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy
Proton beam therapy is a safe irradiation modality for choroidal melanoma. But often after irradiation the exudation increases resulting in an exudative retinal detachment requiring vitreoretinal surgery. It is known that intravitreally injected triamcinolone and TTT is capable to decrease the exudation. If there is any advantage in a combined treatment this study will investigate.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors#1171237
- Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization#1032831
- A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration#896032
- Triamcinolone Injections for Persistent Choroidal Effusions Post Glaucoma Surgery#474837
- Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema#979283
Record · ID 869187
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive